Here’s how pharma should manage its opportunity to keep building trust

Explains why pharma, which has seen an uptick in trust during the pandemic, needs to build on that trust for the long-term benefit of the entire healthcare ecosystem.

This article is part of the May 2021 Spotlight US series, "How the pandemic has changed US healthcare marketing." Read more

The significant role that pharmaceutical companies played in the development and rollout of coronavirus vaccines proved to consumers...